Orally active prostacyclin analogue in primary pulmonary hypertension-Reference-Cited by-同舟云学术

Orally active prostacyclin analogue in primary pulmonary hypertension

Published:1997-05 Issue:9062 Volume:349 Page:1365
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Okano Yoshiaki,Yoshioka Takao,Shimouchi Akito,Satoh Toru,Kunieda Takeyoshi

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst;N EnglJ Med,1996

2. The effect of high-dose calcium channel blockers on survival in primary pulmonary hypertension;Rich;N EnglJ Med,1992

3. Effects of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation;Sim;Arzneimittelforshung,1985

4. Survival in patients with primary pulmonary hypertension: results from a national prospective registry;D'Alonzo;Ann Intern Med,1991

5. Primary pulmonary hypertension: natural history and the importance of thrombosis;Fuster;Circulation,1984

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet strategies: past, present, and future;Journal of Thrombosis and Haemostasis;2023-12

2. A Literature Review of Pulmonary Arterial Hypertension (PAH);Current Respiratory Medicine Reviews;2022-05

3. Catalytic Asymmetric C(sp3)–H Carbene Insertion Approach to Access Enantioenriched 3-Fluoroalkyl 2,3-Dihydrobenzofurans;ACS Catalysis;2021-11-11

4. Clinical Outcomes and Treatment Options in Patients With Pulmonary Hypertension Who Received Pulmonary Hypertension-Specific Drugs　― Single-Center Case Series ―;Circulation Reports;2019-09-10

5. Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension　― Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE) ―;Circulation Reports;2019-07-10